MYRIAD AFTER MYRIAD: THE PROPRIETARY DATA DILEMMA

Myriad Genetics' long-time monopoly on BRCA gene testing was significantly narrowed by the Supreme Court's decision in , and will be further narrowed in the next few years as many of its still-valid patents expire. But these developments have not caused the company to acquiesce in competit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:North Carolina journal of law & technology 2014-06, Vol.15 (4), p.597-637
Hauptverfasser: Conley, John M, Cook-Deegan, Robert, Lázaro-Muñoz, Gabriel
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!